MEREDITH LACAILLADE: Open Payments
NPI 1275844797 · HIGHLAND PARK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$572 in 25 payments from 8 companies in 2025. Trend: 2023 $122 · 2024 $361 · 2025 $572
Food & beverage: $572
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 9 | $219 |
| ARS Pharmaceuticals Operations, Inc. | 5 | $115 |
| AstraZeneca Pharmaceuticals LP | 4 | $80 |
| GlaxoSmithKline, LLC. | 3 | $60 |
| Genentech USA, Inc. | 1 | $29 |
| Novartis Pharmaceuticals Corporation | 1 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Hikma Pharmaceuticals USA | 1 | $19 |
Products named: DUPIXENT, NEFFY, NUCALA, TEZSPIRE, Xolair, CUVITRU, AIRSUPRA, Ryaltris.
Industry payments across IL — which companies pay providers there.
